Mieczkowski, A.; Trzybiński, D.; Wilczek, M.; Psurski, M.; Bagiński, M.; Bieszczad, B.; Mroczkowska, M.; Woźniak, K.
(S)-2-(4-Chlorobenzoyl)-1,2,3,4-tetrahydrobenzo[e]pyrazino[1,2-a][1,4]diazepine-6,12(11H,12aH)-dione—Synthesis and Crystallographic Studies. Molbank 2017, 2017, M964.
https://doi.org/10.3390/M964
AMA Style
Mieczkowski A, Trzybiński D, Wilczek M, Psurski M, Bagiński M, Bieszczad B, Mroczkowska M, Woźniak K.
(S)-2-(4-Chlorobenzoyl)-1,2,3,4-tetrahydrobenzo[e]pyrazino[1,2-a][1,4]diazepine-6,12(11H,12aH)-dione—Synthesis and Crystallographic Studies. Molbank. 2017; 2017(4):M964.
https://doi.org/10.3390/M964
Chicago/Turabian Style
Mieczkowski, Adam, Damian Trzybiński, Marcin Wilczek, Mateusz Psurski, Maciej Bagiński, Bartosz Bieszczad, Magdalena Mroczkowska, and Krzysztof Woźniak.
2017. "(S)-2-(4-Chlorobenzoyl)-1,2,3,4-tetrahydrobenzo[e]pyrazino[1,2-a][1,4]diazepine-6,12(11H,12aH)-dione—Synthesis and Crystallographic Studies" Molbank 2017, no. 4: M964.
https://doi.org/10.3390/M964
APA Style
Mieczkowski, A., Trzybiński, D., Wilczek, M., Psurski, M., Bagiński, M., Bieszczad, B., Mroczkowska, M., & Woźniak, K.
(2017). (S)-2-(4-Chlorobenzoyl)-1,2,3,4-tetrahydrobenzo[e]pyrazino[1,2-a][1,4]diazepine-6,12(11H,12aH)-dione—Synthesis and Crystallographic Studies. Molbank, 2017(4), M964.
https://doi.org/10.3390/M964